Related Funds
Fund Name | Location |
ASI Ventures | - |
Barunson E&A | Seoul-t'ukpyolsi, South Korea, Yongsan |
Credit Mutuel Arkea | Bretagne, France, Le Relecq-kerhuon |
Duopharma Biotech | Malaysia, Selangor, Selangor |
ESSEC Ventures | Cergy-pontoise, France, Ile-de-France |
Heihe asset management | - |
Innovation Norway | Norway, Oslo |
Jinjiang Capital | Changzhou, China, Zhejiang |
MID Venture Capital | Chiyoda, Japan |
Morgan Creek Digital | Chapel Hill, North Carolina, United States |
Orca Capital | China, Shanghai |
Pharmstandard International | - |
Shanghai Qifeng Investement Management Co.,Ltd. | China, Shanghai |
Shilan Zichan Guanli | - |
The Sparkle Fund | - |
Transformation Capital | Boston, Massachusetts, United States |
VIC Partners | - |
Visary Capital | - |
William Morris Agency | Beverly Hills, California, United States |
Zhuhaishi Tongxin Touzi Co., Ltd | China, Guangdong, Zhuhai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Tripvivid | $3M | 08 May 2017 | Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Tripvivid | $3M | 08 May 2017 | Beijing |